Search Results - "Turner, Kenneth"

GGR Handbook of Rock and Mineral Analysis Chapter 6 (Part 1) Principles and Practice of X‐Ray Fluorescence Spectrometry –1: Fundamentals of XRF and Matrix Corrections by Turner, Kenneth E., Webber, Elizabeth

“…This chapter (Principles and Practice of X‐Ray Fluorescence Spectrometry – 1: Fundamentals of XRF and Matrix Corrections) is a contribution to the Geostandards…”
Get full text

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 by Weinreich, David M, Sivapalasingam, Sumathi, Norton, Thomas, Ali, Shazia, Gao, Haitao, Bhore, Rafia, Musser, Bret J, Soo, Yuhwen, Rofail, Diana, Im, Joseph, Perry, Christina, Pan, Cynthia, Hosain, Romana, Mahmood, Adnan, Davis, John D, Turner, Kenneth C, Hooper, Andrea T, Hamilton, Jennifer D, Baum, Alina, Kyratsous, Christos A, Kim, Yunji, Cook, Amanda, Kampman, Wendy, Kohli, Anita, Sachdeva, Yessica, Graber, Ximena, Kowal, Bari, DiCioccio, Thomas, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary, Yancopoulos, George D

“…An anti–SARS-CoV-2 antibody cocktail was given to patients within 3 days after PCR confirmation of Covid-19. In patients who were antibody-negative at…”
Get full text

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 by Weinreich, David M, Sivapalasingam, Sumathi, Norton, Thomas, Ali, Shazia, Gao, Haitao, Bhore, Rafia, Xiao, Jing, Hooper, Andrea T, Hamilton, Jennifer D, Musser, Bret J, Rofail, Diana, Hussein, Mohamed, Im, Joseph, Atmodjo, Dominique Y, Perry, Christina, Pan, Cynthia, Mahmood, Adnan, Hosain, Romana, Davis, John D, Turner, Kenneth C, Baum, Alina, Kyratsous, Christos A, Kim, Yunji, Cook, Amanda, Kampman, Wendy, Roque-Guerrero, Lilia, Acloque, Gerard, Aazami, Hessam, Cannon, Kevin, Simón-Campos, J. Abraham, Bocchini, Joseph A, Kowal, Bari, DiCioccio, A. Thomas, Soo, Yuhwen, Geba, Gregory P, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary, Yancopoulos, George D

“…This phase 3, placebo-controlled platform trial evaluated a single infusion of casirivimab and imdevimab (REGEN-COV) at 2400-mg and 1200-mg doses in…”
Get full text

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 by O’Brien, Meagan P, Forleo-Neto, Eduardo, Musser, Bret J, Isa, Flonza, Chan, Kuo-Chen, Sarkar, Neena, Bar, Katharine J, Barnabas, Ruanne V, Barouch, Dan H, Cohen, Myron S, Hurt, Christopher B, Burwen, Dale R, Marovich, Mary A, Hou, Peijie, Heirman, Ingeborg, Davis, John D, Turner, Kenneth C, Ramesh, Divya, Mahmood, Adnan, Hooper, Andrea T, Hamilton, Jennifer D, Kim, Yunji, Purcell, Lisa A, Baum, Alina, Kyratsous, Christos A, Krainson, James, Perez-Perez, Richard, Mohseni, Rizwana, Kowal, Bari, DiCioccio, A. Thomas, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary, Yancopoulos, George D, Weinreich, David M

“…Household contacts of persons infected with SARS-CoV-2 are at risk for infection. A single subcutaneous injection of two anti–SARS-CoV-2 monoclonal antibodies…”
Get full text

At the mercy of myself: A thematic analysis of beliefs about losing control by Kelly‐Turner, Kenneth, Radomsky, Adam S.

“…Purpose Concerns about the likelihood, consequences, and meaning of losing control are commonplace across anxiety‐related disorders. However, several…”
Get full text

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial by O’Brien, Meagan P, Forleo-Neto, Eduardo, Sarkar, Neena, Isa, Flonza, Hou, Peijie, Chan, Kuo-Chen, Musser, Bret J, Bar, Katharine J, Barnabas, Ruanne V, Barouch, Dan H, Cohen, Myron S, Hurt, Christopher B, Burwen, Dale R, Marovich, Mary A, Brown, Elizabeth R, Heirman, Ingeborg, Davis, John D, Turner, Kenneth C, Ramesh, Divya, Mahmood, Adnan, Hooper, Andrea T, Hamilton, Jennifer D, Kim, Yunji, Purcell, Lisa A, Baum, Alina, Kyratsous, Christos A, Krainson, James, Perez-Perez, Richard, Mohseni, Rizwana, Kowal, Bari, DiCioccio, A. Thomas, Geba, Gregory P, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary, Yancopoulos, George D, Weinreich, David M

“…IMPORTANCE: Easy-to-administer anti–SARS-CoV-2 treatments may be used to prevent progression from asymptomatic infection to symptomatic disease and to reduce…”
Get full text

Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2 by Lin, Kuan-Ju, Turner, Kenneth C., Rosario, Maria, Harnisch, Lutz O., Davis, John D., DiCioccio, A. Thomas

“…Introduction Casirivimab (CAS) and imdevimab (IMD) are two fully human monoclonal antibodies that bind different epitopes on the receptor binding domain of…”
Get full text

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration by Follmann, Dean, O’Brien, Meagan P., Fintzi, Jonathan, Fay, Michael P., Montefiori, David, Mateja, Allyson, Herman, Gary A., Hooper, Andrea T., Turner, Kenneth C., Chan, Kuo- Chen, Forleo-Neto, Eduardo, Isa, Flonza, Baden, Lindsey R., El Sahly, Hana M., Janes, Holly, Doria-Rose, Nicole, Miller, Jacqueline, Zhou, Honghong, Dang, Weiping, Benkeser, David, Fong, Youyi, Gilbert, Peter B., Marovich, Mary, Cohen, Myron S.

“…While new vaccines for SARS-CoV-2 are authorized based on neutralizing antibody (nAb) titer against emerging variants of concern, an analogous pathway does not…”
Get full text

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19 by Somersan-Karakaya, Selin, Mylonakis, Eleftherios, Menon, Vidya P, Wells, Jason C, Ali, Shazia, Sivapalasingam, Sumathi, Sun, Yiping, Bhore, Rafia, Mei, Jingning, Miller, Jutta, Cupelli, Lisa, Forleo-Neto, Eduardo, Hooper, Andrea T, Hamilton, Jennifer D, Pan, Cynthia, Pham, Viet, Zhao, Yuming, Hosain, Romana, Mahmood, Adnan, Davis, John D, Turner, Kenneth C, Kim, Yunji, Cook, Amanda, Kowal, Bari, Soo, Yuhwen, DiCioccio, A Thomas, Geba, Gregory P, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary A, Yancopoulos, George D, Weinreich, David M

“…The open-label RECOVERY study reported improved survival in hospitalized, SARS-CoV-2 seronegative patients treated with casirivimab and imdevimab (CAS + IMD)…”
Get full text

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function by Moore, Kenneth T., Vaidyanathan, Seema, Natarajan, Jaya, Ariyawansa, Jay, Haskell, Lloyd, Turner, Kenneth C.

“…Two previously conducted rivaroxaban studies showed that, separately, renal impairment (RI) and concomitant administration of erythromycin (P‐glycoprotein and…”
Get full text

Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study by Stahl, Andreas, Azuma, Noriyuki, Wu, Wei-Chi, Lepore, Domenico, Sukgen, Emine, Nakanishi, Hidehiko, Mazela, Jan, Leal, Sergio, Pieper, Alexander, Schlief, Sarah, Eissing, Thomas, Turner, Kenneth C., Zhao, An, Winkler, Julia, Höchel, Joachim, Köfüncü, Evra, Zimmermann, Torsten

Get full text

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial by Herman, Gary A, O'Brien, Meagan P, Forleo-Neto, Eduardo, Sarkar, Neena, Isa, Flonza, Hou, Peijie, Chan, Kuo-Chen, Bar, Katharine J, Barnabas, Ruanne V, Barouch, Dan H, Cohen, Myron S, Hurt, Christopher B, Burwen, Dale R, Marovich, Mary A, Musser, Bret J, Davis, John D, Turner, Kenneth C, Mahmood, Adnan, Hooper, Andrea T, Hamilton, Jennifer D, Parrino, Janie, Subramaniam, Danise, Baum, Alina, Kyratsous, Christos A, DiCioccio, A Thomas, Stahl, Neil, Braunstein, Ned, Yancopoulos, George D, Weinreich, David M

“…There is an unmet need for COVID-19 prevention in patient populations who have not mounted or are not expected to mount an adequate immune response to complete…”
Get full text

Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study by Stahl, Andreas, Azuma, Noriyuki, Wu, Wei-Chi, Lepore, Domenico, Sukgen, Emine, Nakanishi, Hidehiko, Mazela, Jan, Leal, Sergio, Pieper, Alexander, Schlief, Sarah, Eissing, Thomas, Turner, Kenneth C., Zhao, An, Winkler, Julia, Höchel, Joachim, Köfüncü, Evra, Zimmermann, Torsten

“…Background There are no data on pharmacokinetics, pharmacodynamics, and immunogenicity of intravitreal aflibercept in preterm infants with retinopathy of…”
Get full text

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19 by Isa, Flonza, Forleo-Neto, Eduardo, Meyer, Jonathan, Zheng, Wenjun, Rasmussen, Scott, Armas, Danielle, Oshita, Masaru, Brinson, Cynthia, Folkerth, Steven, Faria, Lori, Heirman, Ingeborg, Sarkar, Neena, Musser, Bret J., Bansal, Shikha, O'Brien, Meagan P., Turner, Kenneth C., Ganguly, Samit, Mahmood, Adnan, Dupljak, Ajla, Hooper, Andrea T., Hamilton, Jennifer D., Kim, Yunji, Kowal, Bari, Soo, Yuhwen, Geba, Gregory P., Lipsich, Leah, Braunstein, Ned, Yancopoulos, George D., Weinreich, David M., Herman, Gary A.

“…•Phase 1 study assessed monthly casirivimab+imdevimab (CAS+IMD) in uninfected adults•Repeat monthly CAS+IMD (1200 mg subcutaneously [SC]) was well-tolerated,…”
Get full text

Policy conflicts in home automation by Maternaghan, Claire, Turner, Kenneth J.

“…The nature of home automation is introduced. It is argued that end users should be able to define how the home system reacts to changing circumstances…”
Get full text

Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study by Norton, Thomas D, Thakur, Mazhar, Ganguly, Samit, Ali, Shazia, Chao, Jesse, Waldron, Alpana, Xiao, Jing, Patel, Yogesh, Turner, Kenneth C, Davis, John D, Irvin, Susan C, Pan, Cynthia, Atmodjo-Watkins, Dominique, Hooper, Andrea T, Hamilton, Jennifer D, Subramaniam, Danise, Bocchini, Joseph A, Kowal, Bari, DiCioccio, A. Thomas, Bhore, Rafia, Geba, Gregory P, Cox, Edward, Braunstein, Ned, Dakin, Paula, Herman, Gary A

“…ObjectivePregnant women with COVID-19 are at elevated risk for severe outcomes, but clinical data on management of these patients are limited. Monoclonal…”
Get full text

In vitro analysis of the anthelmintic activity of forage chicory (Cichorium intybus L.) sesquiterpene lactones against a predominantly Haemonchus contortus egg population by Foster, Joyce G., Cassida, Kimberly A., Turner, Kenneth E.

“…The anthelmintic activity of chicory (Cichorium intybus L.) herbage has been attributed to sesquiterpene lactones. Chicory leaves contain significant amounts…”
Get full text

Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip by Lin, Kuan‐Ju, Turner, Kenneth C., Hassan, Hazem E., Harnisch, Lutz O., Davis, John D., DiCioccio, Albert Thomas

“…Osteoarthritis (OA) pain management options are currently limited. Fasinumab, an anti‐nerve growth factor monoclonal antibody, has been investigated in healthy…”
Get full text

REGEN-COV ® antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification by Irvin, Susan C, Ganguly, Samit, Weiss, Rachel, Elango, Chinnasamy, Zhong, Xuefei, Mao, Yuan, Yan, Hong, Li, Ning, Sumner, Giane, Turner, Kenneth C, Davis, John D, DiCioccio, A Thomas, Andisik, Matthew D, Partridge, Michael A, Torri, Albert

“…In response to the COVID-19 pandemic, Regeneron developed the anti-SARS-CoV-2 monoclonal antibody cocktail, REGEN-COV (RONAPREVE outside the USA). Drug…”
Get full text

COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes by O'Brien, Meagan P., Forleo-Neto, Eduardo, Musser, Bret J., Isa, Flonza, Chan, Kuo-Chen, Sarkar, Neena, Bar, Katharine J., Barnabas, Ruanne V., Barouch, Dan H., Cohen, Myron S., Marovich, Mary A., Hou, Peijie, Heirman, Ingeborg, Davis, John D., Turner, Kenneth C., Ramesh, Divya, Mahmood, Adnan, Purcell, Lisa, Hooper, Andrea T., Hamilton, Jennifer D., Kim, Yunji, Baum, Alina, Kyratsous, Christos A., Krainson, James, Perez-Perez, Richard, Mohseni, Rizwana, Kowal, Bari, DiCioccio, A. Thomas, Stahl, Neil, Lipsich, Leah, Braunstein, Ned, Herman, Gary, Yancopoulos, George D., Weinreich, David M.

“…In a Phase 3 prevention trial, the monoclonal antibody combination casirivimab and imdevimab (REGEN-COVTM) administered subcutaneously (SC) prevented…”
Get full text